A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people with heart failure, according to a new study.Video above: Can Ozempic, Wegovy cut chronic kidney disease risk?The medication, finerenone, could be an effective therapy in people with heart failure who have mildly reduced or preserved ejection fraction, suggests the study, published Sunday in the New England Journal of Medicine.”People don’t realize this, but if you’re hospitalized for heart failure, you have a life expectancy that can be worse than most cancers, and so we have been desperately looking for therapies that can lower that risk,” said Dr. Scott Solomon, professor of medicine at Harvard Medical School and the Edward D. Frohlich Distinguished Chair at Brigham and Women’s Hospital, who was a trial principal investigator in the study.”We’ve …
Categories